Hikma Pharmaceuticals Plc Director/PDMR Shareholding (9314J)
16 Aprile 2020 - 4:07PM
UK Regulatory
TIDMHIK
RNS Number : 9314J
Hikma Pharmaceuticals Plc
16 April 2020
Hikma Pharmaceuticals PLC
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
Said Darwazah
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Said Darwazah
2 Reason for the notification
a) Position/status Executive Chairman
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Conditional Shares acquired from the grant made
transaction on 13 April 2017 and vested on 14 April 2020
under the 2014 EIP Element C.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 36,438
d) Aggregated information N/A
e) Date of the transaction 15 April 2020
f) Place of the London Stock Exchange (XLON)
transaction
Mazen Darwazah
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Mazen Darwazah
2 Reason for the notification
a) Position/status Executive Vice Chairman
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Conditional Shares acquired from the grant made
transaction on 13 April 2017 and vested on 14 April 2020
under the 2014 EIP Element C.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 19,318
d) Aggregated information N/A
e) Date of the transaction 15 April 2020
f) Place of the London Stock Exchange (XLON)
transaction
Majda Labadi
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Majda Labadi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Conditional Shares acquired from the grant made
transaction on 13 April 2017 and vested on 14 April 2020
under the 2014 EIP Element C.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 16,146
d) Aggregated information N/A
e) Date of the transaction 15 April 2020
f) Place of the London Stock Exchange (XLON)
transaction
Riad Mishlawi
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Riad Mishlawi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Conditional Shares acquired from the grant made
transaction on 13 April 2017 and vested on 14 April 2020
under the 2014 EIP Element C.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 20,146
d) Aggregated information N/A
e) Date of the transaction 15 April 2020
f) Place of the London Stock Exchange (XLON)
transaction
Bassam Kanaan
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Bassam Kanaan
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Conditional Shares acquired from the grant made
transaction on 13 April 2017 and vested on 14 April 2020
under the 2014 EIP Element C.
c) Price(s) and Price(s): GBP22.82
volume(s) Volume(s): 23,233
d) Aggregated information Number of Shares: 23,233
Price: GBP530,177
e) Date of the transaction 14 April 2020
f) Place of the London Stock Exchange (XLON)
transaction
Khalid Nabilsi
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Khalid Nabilsi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Conditional Shares acquired from the grant made
transaction on 13 April 2017 and vested on 14 April 2020
under the 2014 EIP Element C.
c) Price(s) and Price(s): GBP22.82
volume(s) Volume(s): 23,751
d) Aggregated information Number of Shares: 23,751
Price: GBP541,998
e) Date of the transaction 14 April 2020
f) Place of the London Stock Exchange (XLON)
transaction
Susan Ringdal
a) Name Susan Ringdal
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the exercise of nil-cost
transaction options granted on 17 May 2013 and 11 June 2014
under the 2007 LTIP and nil-cost options granted
on 10 April 2015 under the 2014 EIP Elements
B and C
c) Price(s) and Share Plan Price Volume
volume(s) 2013 LTIP GBP22.82 18,424
---------- -------
2014 LTIP GBP22.82 11,774
---------- -------
2015 EIP B GBP22.82 6,006
---------- -------
2015 EIP C GBP22.82 6,006
---------- -------
d) Aggregated information Number of Shares: 42,210
Price: GBP963,232
e) Date of the transaction 15 April 2020
f) Place of the London Stock Exchange (XLON)
transaction
Brian Hoffmann
a) Name Brian Hoffmann
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of nil-cost
transaction options granted on 11 May 2016 and 13 April
2017 under the 2014 EIP Element B.
c) Price(s) and Share Plan Price Volume
volume(s) 2016 EIP B GBP22.34 8,230
---------- -------
2017 EIP B GBP22.34 9,327
---------- -------
d) Aggregated information Number of Shares: 17,557
Price: GBP392,223
e) Date of the transaction 16 April 2020
f) Place of the London Stock Exchange (XLON)
transaction
a) Name Brian Hoffmann
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Disposal of Shares.
transaction
c) Price(s) and Price(s): GBP22.79
volume(s) Volume(s): 2,219
d) Aggregated information Number of Shares: 2,219
Price: GBP50,571
e) Date of the transaction 14 April 2020
f) Place of the London Stock Exchange (XLON)
transaction
Peter Speirs
Company Secretary, responsible for releasing this
announcement
16 April 2020
+44 (0) 20 7399 2760
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHBSGDSUGBDGGL
(END) Dow Jones Newswires
April 16, 2020 10:07 ET (14:07 GMT)
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Apr 2023 a Apr 2024
